U.S. Oil and Gas Stock News

SiteOne Landscape Supply (SITE) has been drawing attention after a stretch of weaker share performance, with the stock down about 21% over the past month and about 25% over the past 3 months. See our latest analysis for SiteOne Landscape Supply. With the share price down 20.53% over the past 30 days and 25.29% over 3 months, while the 1 year total shareholder return is only down 6.98%, recent weakness appears more like fading momentum than a sudden shift in the long term picture. If this kind...

Event driven snapshot of Versant Media Group Versant Media Group (VSNT) has drawn investor attention after a recent period where its stock declined 1.6% in the latest session, while posting gains over the past week, month, and past 3 months. See our latest analysis for Versant Media Group. That 1 day share price decline sits against a 7 day and 30 day share price return in the low single digits, but a much stronger 90 day share price return of 41.9%, suggesting momentum has been building even...

Recent analysis of Nicolet Bankshares (NIC) highlights trends in net interest income growth, net interest margin expansion, and tangible book value per share, providing investors with updated context for assessing the bank's operational performance. See our latest analysis for Nicolet Bankshares. At a share price of $140.84, Nicolet Bankshares has seen its short term momentum soften, with the 30 day share price return down 11.01% and the 90 day share price return down 10.68%, while the year...

GCT Semiconductor Holding (GCTS) is on investors’ radar after signing a reference platform agreement with one of the world’s largest satellite communications providers, extending its existing 5G and 4G chipset licensing relationship. See our latest analysis for GCT Semiconductor Holding. The reference platform announcement has coincided with very strong short term trading interest, with a 1 day share price return of 40.98% and a 30 day share price return of 98.46%. However, the 3 year total...

United Community Banks (NYSE:UCB) plans to acquire Peach State Bancshares, with regulatory and shareholder approval targeted by the third quarter of 2026. The company also announced an agreement to acquire Candid Therapeutics in a deal valued at up to US$2.2b. These transactions expand UCB's reach in traditional banking while adding exposure to a new business segment through Candid Therapeutics. United Community Banks operates as a regional banking company, so adding Peach State Bancshares...

Denali Therapeutics (NasdaqGS:DNLI) received FDA approval for AVLAYAH, its first commercial drug for pediatric Hunter syndrome. The company reported a strong early launch for AVLAYAH, highlighting initial commercial traction for its brain penetrant platform. This milestone marks Denali's transition from a development focused biotech to a commercial stage company. The approval provides an initial test of Denali's approach to delivering therapies across the blood brain barrier for neurological...

Fresh guidance and earnings reset the conversation around Marqeta stock Marqeta (MQ) has moved back into focus after first quarter results topped Wall Street expectations, coupled with company guidance that points to continued revenue and gross profit growth in the second quarter. See our latest analysis for Marqeta. Despite the upbeat Q1 earnings and Q2 guidance, Marqeta’s 1-day share price return of 3.41% to US$3.94 only partly offsets a weaker trend. The 30-day share price return is down...

Datadog (NasdaqGS:DDOG) took part in Dust's US$40 million Series B funding round to help scale Dust's multiplayer AI platform. The move links Datadog more closely to AI-native collaboration tools that aim to connect multiple users and AI agents inside enterprise workflows. This development has drawn attention because it touches Datadog's role in observability, AI-driven operations, and collaboration infrastructure. Datadog is best known for its cloud monitoring and observability tools, but...

Cimpress (CMPR) has drawn fresh attention after announcing a US$525 million senior notes offering due 2032, completing a repricing of its Term Loan B to lower its cost of capital, and scheduling a virtual investor day. See our latest analysis for Cimpress. The US$525 million notes offering, lower cost Term Loan B, and upcoming investor events come on the back of strong momentum, with Cimpress posting a 26.73% 30 day share price return and a 1 year total shareholder return of 128.52%. If you...

Pony AI, listed as NasdaqGS:PONY, reported its first-ever quarterly GAAP net profit. The profit was linked to robotaxi revenue and demand during the recent China Labor Holiday. The company reported record demand growth for its robotaxi services over that holiday period. Management highlighted the role of recent fleet expansions and customer adoption in this performance. Pony AI focuses on autonomous driving technology and operates robotaxi services, an area that has attracted significant...

Recent performance snapshot National Energy Services Reunited (NESR) has drawn attention after a period of strong share price performance, with the stock up around 7% over the past month and about 6% over the past 3 months. See our latest analysis for National Energy Services Reunited. With the latest share price at $25.99, the stock’s recent strength sits on top of a very strong 1-year total shareholder return of about 3x and an even larger 3-year total shareholder return. This suggests...

In early May 2026, Haemonetics Corporation reported fourth-quarter sales of US$346.35 million but moved from a prior-year profit to a US$20.15 million net loss, while full-year sales slipped to US$1.33 billion and net income fell to US$97.31 million, alongside the completion of a US$175 million share buyback program. The combination of weaker profitability despite higher quarterly sales and a sizeable reduction in shares outstanding raises important questions about how earnings quality,...

In May 2026, Orchestra BioMed announced an updated clinical and regulatory timeline for the BACKBEAT Trial of AVIM Therapy in pacemaker-indicated patients with uncontrolled hypertension, including FDA-approved sample-size reduction under the Breakthrough Devices program and Medtronic’s plan to seek FDA and global approvals if primary endpoints are met. The revised trial design, which maintains more than 90% statistical power to detect at least a 5 mmHg 24-hour ambulatory systolic blood...

Why GigaCloud Technology Stock Is On Investors’ Radar GigaCloud Technology (GCT) has drawn attention after a volatile stretch, with the stock up about 3% in the last session but down roughly 28% over the past month and 5% over the past 3 months. See our latest analysis for GigaCloud Technology. At a share price of $37.30, GigaCloud Technology has seen momentum cool in the short term, with a 30 day share price return down 28%, even though the 1 year total shareholder return is up more than...

Earnings shift puts Vertex (VERX) in focus Vertex (VERX) is back on investors’ radar after first quarter results showed revenue of US$196.65 million, compared with US$177.06 million a year earlier, alongside a swing from net income to a US$2.51 million loss. See our latest analysis for Vertex. The stock has been volatile, with a 1-day share price return of 3.19% and a 30-day share price return of 7.37%. However, the year-to-date share price return is down 30.25% and the 1-year total...

Westlake Corporation recently reported first-quarter 2026 results showing sales of US$2,652 million versus US$2,846 million a year earlier and a net loss of US$169 million, and subsequently declared a regular first-quarter 2026 dividend of US$0.53 per share, paid on June 11, 2026 to shareholders of record on May 27, 2026. An interesting contrast for investors is Westlake’s decision to maintain its regular dividend despite reporting a wider quarterly loss than in the prior year. We’ll now...

Celsius Holdings reported past first-quarter 2026 results with sales of US$782.62 million and net income of US$110.1 million, alongside ongoing share repurchases totaling 1,642,177 shares for US$66.02 million under its existing program. The company also highlighted the growing contribution of its multi-brand “Modern Energy” portfolio, including the integrated Alani Nu business, which is supporting both revenue growth and margin improvement through SKU optimization and supply chain...

In recent weeks, PPG Industries has faced pressure as concerns about shrinking profit margins, softer global demand for its industrial coatings, and reduced 2026 earnings estimates have weighed on sentiment. At the same time, a new grant of 457 restricted stock units to Vice President and Controller Brian Richard Williams, vesting in 2028, underscores management’s effort to align leadership incentives with the company’s longer-term performance. We’ll now examine how worries about weaker...

Vestis (VSTS) drew fresh attention after reporting quarterly results that turned a prior loss into a profit and came in ahead of expectations, alongside stronger adjusted EBITDA, free cash flow, and upgraded full-year guidance. See our latest analysis for Vestis. The recent earnings surprise and guidance upgrade came alongside strong share price momentum, with an 84.95% year to date share price return and a 102.16% total shareholder return over the past year suggesting sentiment has shifted...

Robert Half (NYSE:RHI) reports that small business hiring optimism is holding up, according to a new company survey. Respondents indicate growing use of external staffing partners as AI generated job applications make screening candidates more complex. The survey points to a shift in how smaller firms source and assess talent, with staffing specialists playing a larger role. For investors tracking NYSE:RHI, this survey sits within the company’s core business of professional staffing and...

LiveRamp Holdings (RAMP) has just posted its FY 2026 numbers, with fourth quarter revenue of US$206.1 million and basic EPS of US$1.12, alongside net income from ongoing operations of US$69.7 million and an additional US$1.2 million from discontinued operations. Over recent periods, revenue has moved from US$188.7 million in FY 2025 Q4 to US$206.1 million in FY 2026 Q4, while quarterly basic EPS shifted from a loss of US$0.10 in FY 2025 Q4 to a profit of US$1.12 in FY 2026 Q4. This sets up a...

Par Pacific Holdings, Inc. recently completed a US$500 million private placement of 7.375% senior unsecured notes due June 1, 2034, alongside amendments to expand and extend its asset-based revolving credit facility, while also reporting first-quarter 2026 results with higher sales and a swing to net income versus the prior year. At the same time, the company has been active in reshaping its capital structure through debt refinancing and share repurchases, choices that interact directly with...

In the first quarter of 2026, Klarna Group plc reported revenue of US$1,012 million versus US$701 million a year earlier, with net loss narrowing to US$5 million and loss per share improving to US$0.01, while guiding second-quarter revenue to US$960–US$1,000 million and reaffirming positive full-year expectations. A series of partnerships, including bringing Klarna’s flexible payment options into Google’s Gemini app and Search via Google Pay in the U.S. and expanding to Minor Hotels’...

In recent days, billionaire investor Bill Ackman’s Pershing Square Capital Management disclosed a new core position in Microsoft, while Microsoft expanded key AI partnerships, added Carmine Di Sibio to its board, and secured a legal win as Elon Musk’s lawsuit against OpenAI and Microsoft was dismissed. The combination of a high-profile hedge fund entry, deepening enterprise AI collaborations, and resolution of a major legal overhang has refocused attention on Microsoft’s role at the center...